 created a voluntary program under Medicare Part D. It allowed Part D plans to offer some insulin products for no more than $35 a month. It was active from 2021 to 2023. Fewer than half the plans took part in it. In 2022, Biden signed the Inflation Reduction Act, which included a provision that lowered the out-of-pocket cost for people on Medicare to $35 a month, covered all insulin products.